Tianjin Jingjing Fine Chemicals Co., LTD., a wholly-owned subsidiary of Bohai Chemical Group, is a state-level high-tech enterprise.
The main business of the company is the production of pharmaceutical intermediates and phosgene derivatives, custom synthesis and contract production.The main pharmaceutical intermediates include meropenem branch chain [96034-64-9], ertapenem chain [202476-69-4] and [219909-83-8].The company produces phosgene and produces phosgene derivative chloroformate series products, such as chloroformate-2-ethylhexyl ester [24468-13-1], chlorformate p-nitrobenzyl ester [4457-32-3], etc.
The company has complete production, scientific research and public engineering facilities, with more than 200 sets of 30L to 6000L reactor, which can react from -40 to 140°C.With HPLC, GC and other advanced scientific testing instruments, combined with ICH, GMP2010 and ISO9001 quality assurance system to ensure product quality and customer satisfaction.The company has passed ISO9001 certification.

more >
Year of Establishment:
2005
Total Assets(USD):
choose not to disclose
Total Number of Staff:
less than 10 person
Main Competitive Advantages:
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
Manufacturer
R&D capacity:
Annual Turnover(USD):
choose not to disclose
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Asia,Africa
Other Competitive Advantages:
Patents and Copyrights: